Literature DB >> 4092793

Erythema multiforme (Stevens-Johnson syndrome)--chart review of 123 hospitalized patients.

J R Nethercott, B C Choi.   

Abstract

The charts of 123 patients hospitalized with erythema multiforme were reviewed. Antecedent infections and the administration of drugs were associated with 15 and 32% of the cases, respectively. Pyrexia arthralgia, photosensitivity, abnormal liver function tests and abnormal urine sediment were common findings. The length of stay in hospital was 12.6 +/- 0.7 days (mean +/- SE), time to initial improvement after onset was 10.3 +/- 0.6 days and time to complete resolution was 23.0 +/- 2.4 days. The presence of bullous skin lesions and greater overall severity were associated with longer hospitalization. Antecedent respiratory tract symptoms were related to shorter hospitalization. Steroid therapy was not associated with a shorter time for initial improvement to occur, while the average length of stay in hospital was 4.2 days longer than that for the patients not treated with corticosteroid.

Entities:  

Mesh:

Year:  1985        PMID: 4092793     DOI: 10.1159/000249463

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  5 in total

1.  Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan.

Authors:  Kow-Tong Chen; Shiing-Jer Twu; Hong-Jen Chang; Ruey-Shiung Lin
Journal:  Am J Public Health       Date:  2003-03       Impact factor: 9.308

2.  The role of systemic corticosteroid therapy in erythema multiforme major and stevens-johnson syndrome: a review of past and current opinions.

Authors:  Brent Michaels
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

Review 3.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

4.  Erythema multiforme in children: the steroid debate.

Authors:  Melissa Chan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2013-06       Impact factor: 3.275

5.  Controversies in the Management of Cutaneous Adverse Drug Reactions.

Authors:  Yashpal Manchanda; Sudip Das; Aarti Sarda; Projna Biswas
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.